Q-Line Biotec SME IPO Details, Financials, Valuation & Peers
Explore Q-Line Biotec SME IPO details, including IPO dates, financial statements, valuation, peer comparison and more.
Overview
Q-Line Biotech Ltd., incorporated in 2010, is a company focused on the development, manufacturing, and marketing of a diverse range of diagnostic healthcare products. Their core business involves reagents, including kits and Point-of-Care (POC) devices, as well as consumables. Additionally, Q-Line Biotech manufactures, imports, distributes, and supplies diagnostic equipment.
The company primarily serves diagnostic service providers, hospitals, and medical colleges. Their key manufacturing segments encompass indigenous production of reagents for Clinical Chemistry, Haematology, Immunodiagnostics, Molecular Diagnostics, and Other categories like POC Devices & Rapids, alongside manufacturing and supplying in-vitro diagnostics (IVD) and pathology equipment.
Key highlights of Q-Line Biotech include:
- Established manufacturing capabilities with a focus on R&D, Reverse Engineering, and quality control.
- A diversified product portfolio within the IVD industry.
- A widespread distribution network.
- Long-standing customer relationships.
- An experienced Promoter and Management team.
Objects of the Issue
- To meet working capital requirements
- Repayment of certain borrowing availed by the Company, in part or full
- General Corporate Purposes
- Total
IPO Details
Discover essential information crucial for understanding an IPO, including the Price Band, Fresh Issue, Offer For Sale, Total IPO Size and more. Explore these key details to gain insight into the company's public offering.
| Fields | Details |
|---|---|
| IPO Dates | 21 May - 25 May 2026 |
| IPO Price Band | ₹326 - ₹343 per share |
| Fresh Issue | ₹203.74 crore |
| Offer For Sale | NIL |
| Total IPO Size | ₹214.48 crore |
| Face Value | ₹10 |
| Listing On | NSE SME |
IPO Timeline
Explore important dates like IPO opening, closing, listing and others, outlining the journey of the Public Offering. This will help you grasp the entire IPO journey effortlessly.
| Event | Date |
|---|---|
| IPO Opening Date | 21 May 2026 |
| IPO Closing Date | 25 May 2026 |
| Basis Of Allotment | 26 May 2026 |
| Refunds | 27 May 2026 |
| Demat Transfer | 27 May 2026 |
| IPO Listing Date | 29 May 2026 |
Financial Statements
Explore a comprehensive financial data table showcasing key metrics including revenue, expenses, net income, and others. Gain valuable insights about the company's financial performance at a glance, facilitating informed decision-making and strategic planning for subscribing to the IPO.
| Period Ended | 31 Mar 2023 | 31 Mar 2024 | 31 Mar 2025 | 31 Dec 2025 |
|---|---|---|---|---|
| Assets | 251.58 | 339.25 | 455.49 | 561.34 |
| Total Income | 184.81 | 206.45 | 322.58 | 236.50 |
| Profit After Tax | 32.10 | 34.44 | 28.13 | 38.69 |
| EBITDA | 32.98 | 37.63 | 71.32 | 64.23 |
| NET Worth | 127.37 | 161.81 | 189.95 | -0.04 |
| Reserves and Surplus | 125.79 | 160.24 | 188.37 | 2,12,88,920.00 |
| Total Borrowing | 73.65 | 96.91 | 164.95 | 243.85 |
* NPM represents the net profit margin, calculated as a percentage. All other figures are presented in crore (₹cr)
Peer Comparison
Compare key financial metrics with industry peers to gain valuable insights into the company's performance compared to its competitors.
| Name | P/E | EPS | RoNW | NAV |
|---|
* Revenue in (₹cr), RoNW in (%), EPS, NAV in (₹). P/E ratio is based on the highest price from the IPO price band.
IPO Reservation
| Investor Type | Shares Offered |
|---|---|
| Qualified Institutional Buyer (QIB) | 29,69,200 |
| Non-Institutional Investor (NII/HNI) | 8,91,600 |
| Retail Individual Investor (RII) | 20,79,200 |
Subscription Data from NSE and BSE
As the issue has not yet opened, subscription data is unavailable. However, you can view subscriptions for other ongoing issues here.
IPO Registrar
Purva Sharegistry (India) Private Limited
Phone: +91 022 4961 4132/3190 8810
Email: newissue@purvashare.com
Website: www.purvashare.com
Lead Managers
- 1Hem Securities Ltd.
- 2Share India Capital Services Pvt.Ltd.
Company Address
Q-Line Biotech Ltd.298-281,
Transport Nagar,
Kanpur Road Adjacent Transport Nagar Metro Station
Lucknow, – 226012https://qlinebiotech.com/+91 522-2435570compliance@qlinebiotech.com
FAQs
- What is the issue size of the Q-Line Biotec SME IPO?The Q-Line Biotec SME IPO has an issue size of ₹214.48 crore. This includes a fresh issue of ₹203.74 crore and an offer for sale (OFS) of NIL.
- What is the price band of the Q-Line Biotec IPO?The price band for the Q-Line Biotec IPO is ₹326 - ₹343 per share.
- What are the bidding dates for the Q-Line Biotec IPO?The Q-Line Biotec IPO will open for bidding on 21 May 2026 and close on 25 May 2026.
- What is the allotment date for the Q-Line Biotec IPO?The allotment date for the Q-Line Biotec IPO is 26 May 2026.
- What is the minimum lot size and investment required for the Q-Line Biotec IPO?The minimum lot size for the Q-Line Biotec IPO is 400 shares and the minimum investment required is ₹1,37,200.
- What is the listing date for the Q-Line Biotec IPO?The listing date for the Q-Line Biotec IPO is 29 May 2026.
- What is the Q-Line Biotec IPO grey market premium?The grey market premium (GMP) for the Q-Line Biotec IPO is currently at ₹0, with an expected listing gain of approximately 0%. Remember, the grey market premium is not an official indicator, but it reflects market perception and demand for the IPO shares.